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Background. The study aims to verify if the time of preoperative stabilization (≤24 or >24 hours) could be predictive for the
severity of clinical condition among patients aﬀected by congenital diaphragmatic hernia. Methods. 55 of the 73 patients enrolled
inthestudyachievedpresurgicalstabilizationandunderwentsurgicalcorrection.Respiratoryandhemodynamicindexes,postnatal
scores,theneedforadvancedrespiratorysupport,thelengthofHFOV,trachealintubation,PICU,andhospitalstaywerecompared
between patients reaching stabilization in ≤24 or >24 hours. Results. Both groups had a 100% survival rate. Neonates stabilized
in ≤24 hours are more regular in the postoperative period and had an easier intensive care path; those taking >24 hours showed
more complications and their care path was longer and more complex. Conclusions. The length of preoperative stabilization does
not aﬀect mortality, but is a valid parameter to identify diﬃculties in survivors’ clinical pathway.
1.Introduction
Congenital diaphragmatic hernia (CDH) is a rare but serious
disorder of the newborn, that occurs in 1/2000 to 1/5000 live
births a year, and still has an elevated mortality (20–50%).
The prognosis of these patients, even if it has become better
than in the past, still remains unsatisfactory despite the re-
cent acknowledgements about diagnosis, physiopathology,
and treatment [1, 2].
The degree of lung hypoplasia, the persistence of pul-
monary hypertension, and the rate of antenatal termination
arethemainfactorsthatinﬂuencetheprognosis[3].Further-
more, in the presence of serious cardiac defects, the outcome
of infants with CDH is extremely poor [4]. Associations with
complex syndromes and chromosomal defects also worsen
the prognosis [5].
Theuseofadvancedrespiratorysupporttechniques,such
as extracorporeal membrane oxygenation (ECMO), high-
frequency oscillatory ventilation (HFOV), inhaled nitric
oxide(iNO),andsurfactantadministration,whichhavebeen
introduced over the last 10–15 years for the treatment of
CDH patients, seems to have been able to improve their clin-
ical patterns.
Important progress has also been made through the
international collaboration provided by groups and institu-
tions such as the CDH Study Group, the American Academy,
and the CDH EURO Consortium [6–8]. Their, studies,
involving collections of data and common reports, standard-
ized postnatal management and followup shared by many
centers, have surely done much to promote the awareness
and treatment of this pathology, thereby improving diagnos-
tic and therapeutic approaches.
In addition, many studies underline that CDH outcome
might be inﬂuenced by the choice of undergoing surgical
repair when a state of clinical stability has been achieved
[5, 9–11].
A determining aspect in the whole clinical pathway of
CDH patients, both during pregnancy and after birth, is2 International Journal of Pediatrics
the analysis of factors that could be predictive of outcome,
with regards to both mortality and treatment complexity.
The literature proposes many studies on CDH disease
severity involving the application of both prognosis-related
factors measured singularly during pregnancy or at birth, or
some predictive outcome models and scores [6, 12–16].
This study intends to assess whether the time needed
for CDH patients to obtain preoperative stabilization (≤24
hours or >24 hours) could be predictive for the complexity
of the whole clinical path of such patients.
2.MaterialsandMethods
Between January 2000 and December 2010, 77 consecutive
neonates aﬀected by CDH were treated at the Paediatric
Intensive Care Unit (PICU) of our hospital. Table 1 summa-
rizes the main characteristics of the enrolled patients.
After obtaining written, informed parental consent, all
patients were treated with the same protocol:
(i) continuous intravenous analgosedation with mida-
zolam (2-3mcg/kg/min) and fentanyl (2–4mcg/kg/
h);
(ii) early HFOV used as the ﬁrst choice and conﬁgured
with mean airway pressure (MAP) between 9.5 and
14cmH2O,deltaPbetween26and45cmH2O, 10 Hz
respiratory frequency, inspiratory time 33%, and
FiO2 adjusted to maintain the paO2 between 80 and
100mmHg;
(iii) ﬂuid intake between 60 and 90mL/kg/day;
(iv) volemic expansion with fresh frozen plasma (20–
30mL/kg/die);
(v) cardiac inotropic support with dobutamine and/or
dopamine (5–10mcg/kg/min);
(vi) inhaled nitric oxide started at a dose of 20ppm in the
case of pulmonary hypertension;
(vii) porcine-derived surfactant (70–100mg/kg) adminis-
tered if hypoxia occurred (paO2 < 60mmHg with
FiO2 > 0.8) without pulmonary hypertension asso-
ciated with right-to-left shunt.
Both invasive and noninvasive cardiocirculatory mon-
itoring (heart rate, pre- and postductal systolic, diastolic,
mean blood pressure, and central venous pressure) were per-
formed. Patients also underwent pre- and postductal arterial
oxygen-saturation (SpO2), central body temperature, blood
lactate values, and urine output. Echocardiography was
made to check for cardiovascular anomalies, right and
left ventricle performance, pulmonary artery pressure, and
ductal shunting. Chest X-ray completed the respiratory ev-
aluation, focusing on lung recruitment and mediastinum
alignment.
CDH treatment strategy included medical stabilization
before surgery, which was achieved when the patients
reached and maintained for at least ﬁve hours the regulariza-
tion of the following parameters, irrespective of the day of
evaluation:
Table 1: Perinatal data of 77 patients aﬀected by CDH.
Patient characteristics
Male/female 49 (63.6%)/28 (36.4%)
Birth weight (gr) 2930 ± 485 (range 4300-1800)
Gestational age at delivery (wk) 37 ±2 (range 42–32)
Term/preterm delivery 40 (52%)/37 (48%)
Left/right side 67 (87%)/10 (13%)
Inborn/outborn 71 (92.2%)/6 (7.8%)
Prenatal diagnosis 68 (88.3%)
Associated anomalies 18 (23.4%)
Associated congenital heart diseases 4 (5.2%)
(i) ﬁve respiratory and blood-gas-derived indexes: the
oxygenation index (OI) < 10, the alveolar-arterial
O2 gradient (A-aDO2) < 250mmHg, the arterial-
alveolar O2 tension ratio (a/AO2) > 0.5, paCO2 <
55mmHg and arterial pH > 7.35 during HFOV with
FiO2 ≤ 0.50 and map ≤13;
(ii) four hemodynamic and metabolic parameters: mean
arterial pressure (MAP) within normal level for
gestational age, absence of right-to-left ductal shunt,
urine output ≥1.5mL/kg/h, and lactate blood level
below 3mmol/L.
Only 73 patients were enrolled in the study, since 4
neonates with severe associated congenital heart diseases,
characterized by intracardiac shunts, were excluded. Patent
ductus arteriosus and patent foramen ovale were not classed
as cardiovascular malformations.
T h es u r gi c a la p p r o a c hw a sa b d o m i n a l .As u b c o s t a lt r a n s -
verse muscle cutting incision was made on the site of the
hernia, whose contents were gently reduced in the abdomen.
Most diaphragmatic defects were repaired by direct sutures
of the edges of the defect. A prosthetic material (1mm Gore-
Tex) was used for wide defects (>3.5cm).
The neonates were weaned back to conventional ventila-
tion only postoperatively, when respiratory and blood-gas-
derived indexes became and remained within their normal
range and FiO2 ≤ 0.40, Delta P ≤ 36cmH2O, and map ≤12.
In order to fulﬁl the aim of the study, the CDH patients
w h ow e r ec o n s i d e r e ds t a b l ea n du n d e r w e n ts u r g i c a lr e p a i r
were divided into two groups (patients who became stable
in less than or at 24 hours versus those whose stabilization
required more than 24 hours). The survival rate, the trend
of respiratory and blood-gas-derived and hemodynamic
indexes of medical stabilization (OI, A-aDO2,a / A O 2,a rt e r i a l
pH and paCO2, MAP, absence of right-to-left ductal shunt,
urine output, and lactate level) at three times (PICU
admission, before surgery, and after surgery), the need for
advanced respiratory support (iNO and surfactant) and
other intensive care data (days of HFOV, days of tracheal
intubation, length of stay in PICU and in hospital) were
compared between the two groups. The diﬀerence between
the two groups was also analysed using various neonatal
scores: Apgar score at 1 and 5 minutes, CDHSG (CDH-
Study-Group)equationatbirth,SNAPII(ScoreforNeonatalInternational Journal of Pediatrics 3
Table 2: Trend of respiratory, blood-gas-derived, hemodynamic, and metabolic indexes at the three considered times (PICU admission,
before surgery, after surgery) in the 55 patients stabilized and submitted to surgery, divided into two groups according to the duration of
preoperative stabilization stage (≤24 hours or >24 hours).
PICU admission Before surgery After surgery P
Indexes ≤24h >24h ≤24h >24h ≤24h >24h
OI 12.4 ±12.71 5 .0 ±10.55 .6 ±7.66 .0 ±4.94 .5 ± 6.69 .5 ±8.9n s
A-aDO2 (mmHg) 354 ±158 369 ±167 169 ±122 207 ±105 151 ± 110 220 ±118 0.039
a/AO2 0.28 ±0.20 0.23 ±0.18 0.54 ±0.19 0.45 ±0.25 0.56 ± 0.19 0.41 ±0.23 0.047
paCO2 (mmHg) 46.7 ±4.76 1 .4 ±6.33 7 .4 ± 1.43 9 .5 ±1.93 6 .6 ±1.74 5 .0 ±2.3 0.015
pH 7.29 ±0.19 7.25 ±0.21 7.41 ±0.12 7.44 ±0.09 7.43 ± 0.12 7.42 ±0.15 ns
PAM (mmHg) 41.5 ±8.13 9 .7 ±8.74 2 .3 ± 9.33 8 .9 ±7.74 2 .1 ±6.83 7 .4 ±6.7n s
Urine output (mL/h) 1.65 ±0.84 1.19 ± 0.78 2.14 ±0.77 1.83 ±0.65 1.96 ± 0.91 1.52 ±0.76 0.048
Lactate (mmol/L) 1.8 ±0.42 .1 ±0.71 .2 ±0.51 .5 ±0.41 .4 ± 0.61 .9 ±0.9n s
No R-L shunt 26/33 (79%) 4/22 (19%) 33/33 (100%) 22/22 (100%) 33/33 (100%) 20/22 (90%) ns
Acute Physiology), SNAPPE II (SNAP Perinatal Extension
II), PRISM III (Pediatric Risk of Mortality III), and WHSRpf
(Wilford-Hall/Santa-Rosa formula).
TheApgarscoreat1and5minutesisdeterminedbyeval-
uating the newborn baby on ﬁve simple criteria on a scale
from zero to two, then summing up the ﬁve values thus ob-
tained. Theresulting Apgarscorerangesfromzeroto10.The
ﬁve criteria (Appearance, Pulse, Grimace, Activity, and Res-
piration) are used as a mnemonic aid. Scores 3 and below are
g e n e r a l l yr e g a r d e da sc r i t i c a l l yl o w ,4t o6f a i r l yl o w ,a n d7t o
10 generally normal [17].
The CDHSG score is generated from 2 descriptive data
points (birth weight and 5-minute Apgar) within the ﬁrst 5
minutes of life; the obtained score value divides the neonates
into 3 groups with a predicted low risk (survival rate > 66%),
intermediate risk (survival rate 34–66%), and high risk
(survival rate < 33%) [6].
SNAP II measures the severity of illness in infants by
utilizing physiological data collected during the ﬁrst 12hrs
of care. It consists of six items, including the lowest mean
blood pressure, lowest temperature, lowest pH, lowest PaO2/
FiO2 ratio, urine output, and the presence of multiple sei-
zures. SNAP II has also been modiﬁed for use as a mortality
prediction model (SNAPPE II) by including birth weight,
small-for-gestational age, and low Apgar score. Some dedi-
cated tables relate the obtained score with predicted mortal-
ity [12, 18].
PRISM III is comprised of 17 clinical variables subdi-
vided into 26 ranges that include physiological and laborato-
rymeasurementsthatareweightedonalogisticscale.PRISM
IIIisanadequateindicatorofmortalityprobabilityforheter-
ogeneous patient groups in pediatric intensive care. Patients
withPRISMscoresof>10areconsideredathighrisk[19,20].
WHSRpf formula uses blood gas values measured during
the ﬁrst 24 hours of life to calculate the equation: highest
paO2— highest paCO2,w i t hac u t o ﬀ v a l u eo fz e r oo rg r e a t e r
expected to predict survival [13].
Statistical analysis was performed using univariate logis-
tic regression, Friedman test, Fisher exact test, and Mann-
Whitneytest;thenullhypothesiswasrejectedwhenP<0.05.
3. Results
A total of 77 consecutive patients were aﬀected by CDH,
with an overall survival of 72.7%. The 4 patients with as-
sociated congenital heart diseases excluded from the study
presented 1 left ventricle hypoplasia, 2 Fallot tetralogies, and
1 interventricular defect.
Of the 73 patients included in the study, 55 (75.4%)
reached presurgical stabilization, conﬁrmed by the achieve-
ment of the ﬁve preestablished values of respiratory and
blood-gas-derived indexes and of the four hemodynamic
and metabolic parameters previously speciﬁed. 18 patients
(24.6%) died before surgery, having never achieved clinical
stabilization: 11 of these died within the ﬁrst 24 hours, 5
within 48 hours, and 2 within 72 hours after birth. The cause
of death was the suprasystemic pulmonary hypertension
with right-to-left ductal shunt and the right cardiac failure
associated with acute respiratory failure unresponsive to
treatment.
The 55 patients underwent a surgical correction after a
stabilization interval of 43.9±38.7 hours (range 22–168); 33
reachedclinicalstabilityinlessthanorat24hoursafterPICU
admission (group I), while 22 required a stabilization time of
m o r et h a n2 4h o u r s( g r o u pI I ) ,w i t ham e a no f7 7 .8 ± 45.9
hours after PICU admission (range 30–168).
In both groups submitted to surgery the survival rate was
100%. No deaths occurred among the patients without asso-
ciated congenital heart diseases, but they were considered
stable and submitted to surgical repair of CDH. Survival was
deﬁned as survival to discharge from the hospital.
Table 2 shows that the respiratory and blood-gas-derived
and hemodynamic index values are consistently outside the
normal range at PICU admission, conﬁrming the cardiores-
piratory pattern severity for these patients. The values were
normalized before surgery and after surgery in both groups.
However, more stable and physiological levels can be noted
in the group of patients reaching preoperative stabilization
within 24 hours, in comparison to those who were stabilized
after more than 24 hours. Among the considered indexes, A-
aDO2,a / A O 2,p a C O 2, and urine output showed a statistical
signiﬁcance. Another noteworthy diﬀerence between the two4 International Journal of Pediatrics
Table 3: Comparison of severity scores in the 55 patients stabilized
and submitted to surgery, divided into two groups according to
the duration of preoperative stabilization stage (≤24 hours or >24
hours).
Scores ≤24h >24h P
APGAR 1min 6.3 ±1.65 .1 ±1.9 0.025
APGAR 5min 7.7 ±1.26 .8 ±1.7 0.033
CDHsg 75 ±16 67 ±13 ns
PRISM 13.22 ±4.81 16.81 ±8.32 ns
SNAP II 13.03 ±9.99 19.74 ±17.90 ns
SNAPPE II 18 ±14 32 ±23 0.016
WHSRpf 156 ±109 144 ±111 ns
groups is that in group I the index values after surgery
improved or remained the same as before surgery, whereas
in group II the neonates tended to show a slight worsening of
these indexes immediately after surgery.
In addition, all the predictive outcome models and scores
analysed (Table 3) show worse values, farther outside normal
ranges, and in the neonates who stabilized after 24 hours. In
particular, we underline the fact that the Apgar score at 1
and 5 minutes and SNAPPE II show statistically signiﬁcant
diﬀerences between the two groups.
Finally, the advanced respiratory support application
rates (iNO and surfactant) and certain intensive care timing
indexes(daysofHFO,daysoftrachealintubation,andlength
of stay in PICU and in hospital) were signiﬁcantly higher in
the survivors requiring more than 24 hours for preoperative
stabilization (Table 4).
4. Discussion
CDH shows a broad spectrum of clinical variability, thus
making it very diﬃcult to formulate a correct prognosis. At
birth, in fact, one may ﬁnd moderately compromised clinical
conditions, or, conversely, dramatic cardiorespiratory pat-
terns, that require immediate and highly invasive treatments
that are not always successful [21, 22].
CDH is characterized by a variable degree of pulmonary
hypoplasia associated with a decrease in the number of
bronchial generations, alveoli, and pulmonary vessels and
an increase in the muscularity of the pulmonary vascular
bed. The hypoplastic lung has a small alveolar capillary
membrane for gas exchange, which may be further decreased
by the surfactant system dysfunction. Pulmonary capillary
blood ﬂow is decreased because of the small cross-sectional
area of the pulmonary vascular bed, and ﬂow may be further
decreased by abnormal pulmonary vasoconstriction, which
can be increased by a vicious circle sustained by hypoxia,
hypercapnia, acidosis, and hypothermia [3, 23–25].
The clinical use of advanced respiratory assistance strate-
gies, such as ECMO, HFOV, and iNO administration as a
selective pulmonary vasodilator and surfactant adminis-
tration, has surely improved CDH prognosis, but global
mortality remains high, between 20 and 50%, in reported
case series from all over the world [1, 2, 21, 22].
Table 4: Comparison of advanced respiratory therapies and the
timingofintensivecareandhospitaltreatmentinpatientsstabilized
and submitted to surgery, divided into two groups according to
the duration of preoperative stabilization stage (≤24 hours or > 24
hours).
Parameter ≤24h >24h P
iNO treatment 7/33 (21.2%) 18/22 (81.8%) 0.018
Surfactant treatment 9/31 (29.0%) 11/19 (57.8%) 0.041
HFO (days) 5.2 ±4.67 .4 ±5.2 0.032
IRT (days) 21.6 ±18.22 6 .3 ±17.5 0.228
PICU (days) 23.1 ±13.73 4 .1 ±19.6 0.017
Hospital (days) 35.3 ±12.14 3 .1 ±14.5 0.029
The goal to understand the best timing, according to
the clinical pattern, to perform CDH surgical correction has
reached a good level of consensus in the literature [5, 6, 8–
11, 26–29]. The study by Nakayama et al. , which demon-
strated the utility of preoperative stabilization in improv-
ing respiratory compliance of CDH patients, had a fun-
damental role in proposing delayed surgical treatment [30].
A further step towards understanding the concept of CDH
preoperative timing was achieved with subsequent studies
that demonstrated how the improvement in CDH survival
was due to cardiorespiratory stability more than the time
between birth and surgery [31, 32]. In fact, the aim to
achieve preoperative stabilization, irrespective of the time
taken, is a priority in CDH treatment, since it is well
known that surgical correction performed in a compensated
condition can give the patient more survival chances. This
is possible only with an improvement in respiratory failure
(better ventilation of hypoplastic lung and recruitment of
contralaterallung),andwiththeinterruptionoftheright-to-
left ductal shunt characteristic of suprasystemic pulmonary
hypertension during the phase of CDH decompensation, in
order to ameliorate hemodynamic performance [33–35].
CDH has a number of characteristic anatomical and
physiopathological features, due to the neonatal age and
to the speciﬁc pulmonary malformation. It could therefore
be hypothesized that the use of some speciﬁc indexes and
neonatal scores may be predictive of the severity and the
clinical path of such pathology.
The application of predictive outcome indexes becomes
particularly important in the early postnatal period, during
which estimating the severity of the disease can promptly
indicate the most appropriate therapies to undertake. On the
basis of the achievement of speciﬁc values of ﬁve respiratory
and blood-gas-derived indexes (OI, A-aDO2,a / A O 2,p a C O 2,
and arterial pH) and four hemodynamic and metabolic pa-
rameters(MAP,right-to-leftductalshuntabsence,urineout-
put, and lactate blood level), it was possible to determine the
most opportune moment to submit the patients to surgery.
The respiratory and hemodynamic indexes in question are
often a commonly applied tool to assess the degree of car-
diorespiratoryfailureinneonatalandpaediatricage,butthey
can also well express the compensation conditions in pa-
tients aﬀected by pathologies such as CDH [8, 36–38]. The
literature shows how the failure to achieve validated indexesInternational Journal of Pediatrics 5
fortheassessmentofcardiorespiratorycompensationinneo-
nates aﬀected by CDH may inhibit surgical repair [8, 29, 36,
39]. In our study, in fact, 18 patients died without having
ever achieved a phase of compensation and without being
submitted to surgery. On the other hand, all 55 patients
who achieved preoperative stabilization, irrespective of the
time taken (≤24 hours or >24 hours), presented a 100%
postoperative survival, thus conﬁrming the validity of the
treatment undertaken and of the parameters chosen to
deﬁnepreoperativestabilizationandthemomentforsurgical
repair.
Some of the scores adopted, such as the CDHSG and
WHSRpf, are speciﬁc for the assessment of outcome in CDH
[6, 13]. SNAP II and SNAPPE II, which were initially val-
idated outcome predictors in the non-CDH neonatal popu-
lation, have also been reported as predictors of mortality in
infants with CDH [12]. The Apgar score at 1 and 5 minutes
and PRISM III are more generic scores, in that they assess
respectively the newborn baby at birth and heterogeneous
pediatric patient groups in NICU/PICU [17, 20]. Our data
showsthatthegreatestpartoftheconsideredpostnatalscores
are reliable and concordant in CDH outcome: the values
of these scores are in fact prognostically associated with
a favourable outcome, in line with the complete survival
registeredinpatientsdeﬁnedstableandsubmittedtosurgery.
The present study also shows that the diﬀerent duration
of preoperative stabilization stage (≤24 hours or >24 hours)
isindispensableforassessingthebestmomentineachpatient
to undergo surgical repair; it does not aﬀect mortality given
that all the patients considered stable survived, but can be
considered a reliable index to assess the complexity and
clinical severity of CDH in survivors.
The preoperative stabilization time divides the neonate
survivors into two groups. The ﬁrst is characterised by a nor-
malization of the parameters within 24 hours, immediately
followed by surgery. These patients show a correspondence
between favourable outcome factors, good stability of the
respiratory, blood-gas-derived and hemodynamic values,
and a short clinical path. They belong to the category of pa-
tients that the literature on CDH reports as the most regular
andthemostcompensated[5,9,11,40].Thesecondgroupis
characterized by the need for stabilization times longer than
24 hours and consequently a more delayed surgical repair.
The latter patients are characterized both by more altered
predictive outcome scores and by the fact that all respiratory,
blood-gas-derived, hemodynamic, and metabolic indexes of
clinical stabilization tend to worsen (within normal range)
in the early postoperative period compared to the immediate
preoperative stage and to the patients who became stabilized
in the ﬁrst 24 hours. In addition, these patients needed more
frequent surfactant and iNO administration, and longer
HFOV, tracheal intubation times, and prolonged length of
PICU and hospital stay, if compared with patients needing
lessthan24hourstoachievestability.Someofthemprobably
belong to the category of patients who in the past were
destined for an unfavourable prognosis but who now appear
to have beneﬁtted from the introduction of new treatment
modalities and advanced respiratory support techniques [2,
41, 42].
5. Conclusions
RecentreportscontinuetoconﬁrmthatCDHisaseriousand
severe neonatal pathology still aﬄicted by high mortality,
that can present variable clinical pictures at birth and that
requires immediate and graded steps of treatment depending
on the respiratory distress and the persistence of pulmonary
hypertension [8, 28, 31]. The possibility to have valid and
precise indexes of reference in terms of outcome can help
obtain a prompt and correct therapeutic framework.
Our study conﬁrms the need to submit CDH patients
to surgery only if they have achieved conditions of stability
clearly grounded on precise parameters. Thanks to the
achievementof suchcriteria, surgerycanbe performedwith-
greater conﬁdence and with the knowledge that a high sur-
vival rate can be expected. The study underlines that the
length of preoperative stabilization does not aﬀect mortality,
but has proved a valid index in pinpointing diﬃculties
throughout the patient’s whole pathway. When the time
needed for neonates to achieve stabilization is short (≤24
hours), they remain more stable in the postoperative period
and have an easier and more linear intensive care path; when
the time of preoperative stabilization is longer (>24 hours),
the neonates are more complicated, need more intensive
therapy, and have a longer and more complex care path, even
after surgery.
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